Databricks vs AI Blood Test Analyzer & Interpretation by PIYA.AI: Revenue, Funding & Team Size Compared
Databricks generates $5.4B in revenue; AI Blood Test Analyzer & Interpretation by PIYA.AI has not disclosed its revenue. The table below compares Databricks and AI Blood Test Analyzer & Interpretation by PIYA.AI on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $5.4B | Not disclosed |
| Valuation | $134B | Not disclosed |
| Funding raised | $9B | Not disclosed |
| Customers | 10K | Not disclosed |
| Team size | 8K | Not disclosed |
| Growth | 46% | Not disclosed |
| Founded | 2013 | 2023 |
| HQ | San Francisco, United States | Şişli, Turkey |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Databricks at a glance
Databricks generates $5.4B in revenue with 8K employees, headquartered in San Francisco, United States.
- Revenue
- $5.4B
- Valuation
- $134B
- Funding
- $9B
- Customers
- 10K
- Team size
- 8K
- Founded
- 2013
Databricks is a cloud-based data engineering, data science, and machine learning platform that provides tools for managing and processing large-scale data. The platform offers features such as data integration, automated data engineering…
AI Blood Test Analyzer & Interpretation by PIYA.AI at a glance
- Founded
- 2023
Your AI Blood Test & Lab Test Analyzer, fast, accurate interpretation at your fingertips.
Other Databricks alternatives
Databricks competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Databricks vs AI Blood Test Analyzer & Interpretation by PIYA.AI: frequently asked questions
How much revenue does Databricks make?
Databricks generates $5.4B in annual revenue with a team of 8K.
How much funding has Databricks raised?
Databricks has raised $9B in total funding since it was founded in 2013.